In a recent multinational prospective cohort study, “The Real World EVOLVE Study,” in pregnant women with pre-existing diabetes, insulin detemir was associated with a similar risk to other basal insulins of major congenital malformations perinatal or neonatal death, hypoglycemia, preeclampsia, and stillbirth [17]. This evidence concerns the gene INS and preeclampsia.